Diabetes and heart failure post-acute myocardial infarction: Important associations and need for evidence-based interventions

Abstract

Get full access to this article

View all access options for this article.

References

Ritsinger V, Nyström T, Saleh N, et al. Heart failure is a common complication after acute myocardial infarction in patients with diabetes: A nationwide study in the SWEDEHEART registry. Eur J Prev Cardiol 2020; 27: 1890–1901.

Kannel

McGee

. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035–2038.

Ferrini

Johansson

Aboyans

. Heart failure and its complications in patients with diabetes: mounting evidence for a growing burden. Eur J Prev Cardiol 2019; 26(2-suppl): 106–113.

Roberts

Rogers

Mueller

, et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation 1991; 83: 422–437.

Yusuf

Peto

Lewis

, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335–371.

Franzosi

. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: Systematic overview of individual data from 100,000 patients in randomized trials. Circulation 1998; 97(22): 2202–2212.

Kenny

Abel

. Heart failure in type 2 diabetes mellitus: impact of glucose-lowering agents, heart failure therapies, and novel therapeutic strategies. Circ Res 2019; 124: 121–141.

Zelniker

Wiviott

Raz

, et al. Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus. Circulation 2019; 139: 2022–2031.

Perkovic

Jardine

Neal

, et al. CREDENCE study investigators. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 2019; 380: 2295–2306.

10.

McMurray

JJV

Solomon

Inzucchi

, et al. DAPA-HF Trial Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 2019; 381: 1995–2008.

11.

McNamara

Chung

Jernberg

, et al. International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: the MINAP/NICOR, SWEDEHEART/RIKS-HIA, and ACTION Registry-GWTG/NCDR registries. Int J Cardiol 2014; 175: 240–247.

12.

Fröbert

Lagerqvist

Olivecrona

, et al. TASTE Trial. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 2013; 369: 1587–1597.

13.

Rydén

Ferrannini

Mellbin

. Risk factor reduction in type 2 diabetes demands a multifactorial approach. Eur J Prev Cardiol 2019; 26(2-suppl): 81–91.